A novel proof-of-concept study assessing the lightening effects and safety of malassezin for treatment of facial hyperpigmentation
- 19 October 2021
- journal article
- letter
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 87 (2), 456-458
- https://doi.org/10.1016/j.jaad.2021.10.008
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- The aryl hydrocarbon receptor at the forefront of host‐microbe interactions in the skin: A perspective on current knowledge gaps and directions for future research and therapeutic applicationsExperimental Dermatology, 2021
- 709 Malassezin: A preclinical assessment of a novel microbiome-based skin lightenerJournal of Investigative Dermatology, 2020
- The Malassezia Genus in Skin and Systemic DiseasesClinical Microbiology Reviews, 2012
- Continuous therapy followed by a maintenance therapy regimen with a triple combination cream for melasmaJournal of the American Academy of Dermatology, 2010
- Malassezin, a Novel Agonist of the Aryl Hydrocarbon Receptor from the Yeast Malassezia furfur, Induces Apoptosis in Primary Human MelanocytesChemBioChem, 2005